Real-time, portable genome sequencing for Ebola surveillance J Quick, NJ Loman, S Duraffour, JT Simpson, E Severi, L Cowley, JA Bore, ... Nature 530 (7589), 228-232, 2016 | 1542 | 2016 |
Neuropilin-1 is a host factor for SARS-CoV-2 infection JL Daly, B Simonetti, K Klein, KE Chen, MK Williamson, C Antón-Plágaro, ... Science 370 (6518), 861-865, 2020 | 1282 | 2020 |
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1123 | 2021 |
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 963 | 2022 |
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 862 | 2022 |
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 794 | 2021 |
ACE2: from vasopeptidase to SARS virus receptor AJ Turner, JA Hiscox, NM Hooper Trends in pharmacological sciences 25 (6), 291-294, 2004 | 708 | 2004 |
Virus genomes reveal factors that spread and sustained the Ebola epidemic G Dudas, LM Carvalho, T Bedford, AJ Tatem, G Baele, NR Faria, DJ Park, ... Nature 544 (7650), 309-315, 2017 | 454 | 2017 |
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 445 | 2021 |
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015 | 372 | 2015 |
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 366 | 2021 |
Tissue-specific immunopathology in fatal COVID-19 DA Dorward, CD Russell, IH Um, M Elshani, SD Armstrong, ... American journal of respiratory and critical care medicine 203 (2), 192-201, 2021 | 354 | 2021 |
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein AD Davidson, MK Williamson, S Lewis, D Shoemark, MW Carroll, ... Genome medicine 12, 1-15, 2020 | 342 | 2020 |
Nucleolar targeting: the hub of the matter E Emmott, JA Hiscox EMBO reports 10 (3), 231-238, 2009 | 329 | 2009 |
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 323 | 2021 |
RNA viruses: hijacking the dynamic nucleolus JA Hiscox Nature Reviews Microbiology 5 (2), 119-127, 2007 | 312 | 2007 |
Localization to the nucleolus is a common feature of coronavirus nucleoproteins, and the protein may disrupt host cell division T Wurm, H Chen, T Hodgson, P Britton, G Brooks, JA Hiscox Journal of virology 75 (19), 9345-9356, 2001 | 294 | 2001 |
The coronavirus infectious bronchitis virus nucleoprotein localizes to the nucleolus JA Hiscox, T Wurm, L Wilson, P Britton, D Cavanagh, G Brooks Journal of virology 75 (1), 506-512, 2001 | 282 | 2001 |
Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak LE Kafetzopoulou, ST Pullan, P Lemey, MA Suchard, DU Ehichioya, ... Science 363 (6422), 74-77, 2019 | 266 | 2019 |
The nucleolus–a gateway to viral infection? JA Hiscox Archives of virology 147, 1077-1089, 2002 | 266 | 2002 |